Aprea Therapeutics, Inc.
APRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781983
No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Aprea Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 25 | 18 | −7 |
| SharesConverted for a 1-for-20 split | 79.6K | 848.4K | +768.8K (+965.7%) |
| Value | $521.3K | $3.77M | +$3.25M (+623.2%) |
New holders (6)
Institutions that held Aprea Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AIGH Capital Management LLC | 345,000 | $1.53M | 0.57% |
| Sio Capital Management, LLC | 280,000 | $1.24M | 0.61% |
| Walleye Capital LLC | 93,263 | $415.0K | 0.01% |
| Worth Venture Partners, LLC | 84,869 | $377.7K | 0.19% |
| Princeton Global Asset Management LLC | 100 | $444 | 0.00% |
| Royal Bank of Canada | 23 | $0 | 0.00% |
Sold out (13)
Institutions that held Aprea Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Renaissance Technologies LLC | 179,200 | $59.0K |
| Millennium Management LLC | 164,626 | $53.0K |
| Geode Capital Management, LLC | 149,711 | $48.0K |
| Jane Street Group, LLC | 50,950 | $16.9K |
| State Street Corp | 40,832 | $13.1K |
| Northern Trust Corp | 28,710 | $9.50K |
| Blackstone Group Inc. | 16,590 | $5.49K |
| Sugarloaf Wealth Management, LLC | 15,000 | $4.96K |
| Susquehanna International Group, LLP | 13,365 | $4.30K |
| Stifel Financial Corp | 10,000 | $3.31K |
| Federated Hermes, Inc. | 2,253 | $746 |
| Citadel Advisors LLC | 1,276 | $411 |
| JPMorgan Chase & Co | 4 | $0 |